ESR1 and breast carcinoma: Evaluation of the relationship between the level of lncRNA CASC2 and different clinicopathological parameters of breast cancer tissues showed that in tumors with smaller size, lower grade, lower stage, estrogen receptor positive, and no lymphatic and vascular invasion, the expression of CASC2 gene was significantly higher (p < 0.05, Table 3).